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1. INTRODUCTION 
Solid dosage forms (powders, tablets, capsules) are the most popular ones among all dosage 
forms, as they carry many advantages with their therapeutical use, enabling good patent 
compliance, as well. 
According to the meaning of Drug Delivery in Context, it is the method or process of 
administering a pharmaceutical compound to obtain optimal therapeutic benefit; with its right 
amount, to the right tissues of the body, as well as in proper, right time. 
Powders are encountered in almost every aspect of pharmacy, both in industry and in practice 
[1-5]. 
The smallest items of solid dosage forms are the particles. Although the importance of 
particle size and its rheological aspects (flowability) has become well-known by today, the 
newer and newer technological methods and modern pharmaceutical dosage forms make the 
substantial knowledge of raw materials (ingredients) inevitable. The appearance of mini-
tablets has induced the need to study the role of particle size from new aspects.  
2. AIMS 
The aims of my studies were as follows: 
The primary aim of my Ph.D. Thesis is to present the importance of determining the size 
and shape of solid particles - among the preformulation tests - considering the preparation of 
mini-tablets, as well. 
The findings of the dissertation can be divided into three parts. 
The first section of this work describes the need and the selection of proper and quick 
methods suitable for particle size determination; which are proper to characterize particle size 
 both in the case of raw materials, and finished products. 
Section two deals with the influence of the cohesion coefficient on the flowability of solid 
particles; and the findings permit the prediction of the smallest orifice diameter, which 
enables the particles to flow freely into the die cavity during the process of compaction.  
Section three studies the role of the particle size during the compression process of common 
tablets, and thus makes prediction possible for the compression parameters of mini-tablets. 
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3. LITERATURE SURVEY 
Particle size is now widely accepted as being a critical parameter with a significant impact on 
the performance of pharmaceutical materials at all stages of their production and also on the 
finished product. The U.S. Food and Drug Administration (FDA), - as well as the European 
Medicine Agency (EMA) - is becoming stricter with regard to particle size analysis as a 
quality procedure [1-6]. 
The following aspects justify the particle size determination and the repeated study of 
flowability parameters: 
1. By the preparation of solid dosage forms, it is essential to support their monodispersity; 
especially in the case of direct compression. However, ingredients and products commercially 
available show heterodispersity, as their feature.  
In order to obtain proper particle size, comminution and milling process can be carried out. 
Consequently, the structure of the original crystals might be damaged, thus creating new and 
, resulting in the increase of the speed of dissolution, or 
other undesired interactions. Therefore, during preformulation tests, it is inevitable to check 
the suitability of the procedure. 
2. In case of the preliminary milling process, the use of the so-c -
materials, which seems to be favourable nowadays, should also be taken into consideration. 
These auxillaries (e.g. Ludiflash, PharmaBurst 500, Prosolv ODT, F-melt type C, Parteck 
ODT, etc.) consist of individual particles with multiple components. The unique feature of 
these particles should not be destroyed.  
3. Nowadays the so- -
diameter tends to be between 2-3 mm. In the course of their preparation, during the 
compressional phase, the material should fill out properly the die hole with a diameter of 2-3 
mm. This problem is considered to be a big challenge for pharmaceutical technologists; how 
to plan and how -day- 
methods. 
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3.1 Particle Size Measurement and Classification 
Particle size determination is essential in the following aspects: 
 Safety of drug utilisation, 
 Quality of drugs, 
 Stability of drugs, 
 Standardisation and validation of the various dosage forms [7-9], 
 
characteristics may also influence the rate of absorption [4-5]. 
3.1.1. Statistical Parameters 
Monodisperse systems of particles of regular shape, such as perfect cubes or spheres, can be 
completely described by a single parameter, e.g. a length of a side or diameter. However, 
when either nonuniform size distributions or anisometric shapes exist, any single parameter is 
incapable of totally defining the powder.  
For irregular particles the assigned size will be strongly dependent on the method of 
measurement. 
Mean particle diameter is the most important single statistical parameter since, if the proper 
diameter is chosen, the various other parameters of interest such as specific surface area, 
number, mean particle weight etc., may often be calculated.  
For spherical particles the size is defined by the measurement of the diameter. However, for 
other-shaped particles some other single size designation is generally used, e.g. the diameter 
of a sphere with the same projected area as the nonspheroidal particle being measured. An 
irregularly shaped particle has a number of different dimensions, e.g.
projected area, inscribed circle (dmin), circumscribed circle (dmax). Depending on the method 
of measurement, various diameters are obtained [10-13]. 
In measuring particle size it is important first to select the parameter that is related to the 
ultimate use of the product, and then to select the method that will measure this parameter. 
Methods for particle size measurement can be either direct or indirect ones. Direct methods 
measure the actual dimensions of the particle by use of a calibration scale as in microscopy 
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and sieving. Indirect measurements make use of some characteristic of the particle, which can 
be related to particle size; e.g. sedimentation rates, permeability, and optical properties [14]. 
The simpliest method among all is the sieving analysis, and the use of microscopy is 
considered to be one of the most accurate direct methods.  
A variety of semiautomated and automated procedures have been developed in order to 
reduce any error in connection with the manual counting of particles, e.g. image analysis with 
various softwares. 
Besides these ones, numerous methods suitable for particle size measurement exist, e.g. 
scanning and transmission electron microscopy (SEM, TEM), laser diffraction and 
spectroscopic proceedings (Near Infrared Spectroscopy - NIR). 
3.1.2. Microscope and image analysis 
Referring to Turbitt-Daoust et al., one of the most widely used and well-known methods is the 
microscope combined with an image analysis system, as it is considered to be principal 
among the other ones, gives a general study about the statistical dimensions of the analysis, 
and the method provides excellent reproducibility 11 . Podczeck has pointed out, that the 
results of the measured particles (size, shape, morphology) are considered to be standard data 
in comparison with any other sizing methods or techniques, enables the measurements on 
images from any source, provides rapid and accurate data, replacing the traditional, and rather 
subjective methods 13, 15 . 
Image analysis involves several separate stages: the image is acquired by the hardware, and 
converted into an electrical form, which is stored in the computer memory, or on a mass 
storage system such as a hard disc 12 . 
The results of the measured particles (size, shape and morphology) are considered to be 
standard data for comparison with other sizing methods or techniques.  
In my work, the most important size and feature parameters of the model materials were 
determined by using the Leica Q500 MC image processing and analysis system (applying the 
principles of light microscope equipped with an image analysis system). 
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The software of the image analysis system derives roughness and other shape parameters 
from the measured data. 
3.2 Flowability test 
Particle size and shape have an impact on the powder rheological parameters, especially on 
flowability. 
In flowability studies, the angle of repose is considered to be a parameter that can be 
measured well. An inverse relationship has been reported between the particle size and the 
angle of repose 16 . 
Besides the angle of repose, powder flow can be described by the flow time, the Carr index 
and the Hausner ratio. Powder flow can be characterized in two ways: as mass flow, when the 
particles can flow comparatively easily, as the cohesion between the particles is very low; and 
as funnel flow, when the particles flow much more poorly as the frictional forces acting at the 
funnel wall and the cohesion between the particles are much higher 17  (Fig. 1). In the case 
of mass flow, all of the powder particles in the funnel are in motion 18, 19 . In the case of 
funnel flow, the central core of powder flows from the funnel first, followed by the remaining 
powder from closer to the walls of the funnel. 
 
 
Fig. 1  Types of flow through a funnel 17  
 
Good flowability requires mass flow as in funnel flow the powder particles are held together 
more strongly by cohesion forces. Funnel flow leads to unevenness in filling during 
capsulation or compression, and high deviations can occur in the average mass of capsules of 
tablets. Accordingly, flowability testing is official in the Pharmacopoeias, and it is necessary 
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to investigate flowability in the preformulation tests in the process of development of a solid 
dosage form. The multiparticulate dosage forms that are currently at the focus of therapy 
include hard capsules filled with mini-tablets, which are very small tablets (2 3 mm in 
diameter). This means that good flowability is especially important during the manufacturing 
of these tablets, where the diameter of the dies is very small and the filling time is also very 
short 16-19 . 
3.3 Near-infrared Spectroscopy (NIR) 
Among the numerous techniques for the measurement of particle features, near-infrared 
(NIR) spectroscopy is an alternative method, which plays an increasing role in manufacturing 
as industry strives to improve the quality and process efficiency while reducing the costs. The 
wavelength range that constitutes the NIR region of the electromagnetic spectrum, and the 
demarcation of that range from other spectral regions, are somewhat indistinct. NIR is 
interpreted by BL-Analytics as the area between the visible and the infrared regions, thus 
covering the range from around 800 nm to 2500 nm.  
The absorption bands observed in NIR spectra originate from overtones of hydrogen-
stretching vibrations or from combinations of stretching and bending modes of vibration [20]. 
Since the absorption in the NIR region is much weaker than in the middle-IR region, NIR 
spectra can be obtained by direct measurement on samples without dilution, an integrating 
sphere being used to measure the diffuse reflection [21]. 
As the reflectance of solid samples varies with the concentration, the absorptivity and the 
scattering coefficient according to the Kubelka Munk theory [22], the NIR spectrum of a 
solid material depends both on its chemical composition and on its physical properties, such 
as the particle size and surface characteristics [23-26]. 
Reflection spectroscopy is the study of light reflected from the surface of a sample, rather 
than the light transmitted through the sample. Light reflection can be either specular or 
diffuse. Diffuse reflection is reflection that occurs in all directions from the surface as a result 
of absorption and scattering processes.  
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The reflectance (R%) can be introduced on the analogy of transmittance: 
100
I
I
R% )(
O
R   Eq. (1) 
where IR is the intensity of the diffusely reflected light collected by the integrating sphere, and 
I0  is the intensity of the incident light. 
The absorbance can be interpreted as the logarithm of the reciprocal reflectance: A=log(1/R). 
The relationship between diffusively reflected spectral values involving the scattering of solid 
particles can be evaluated by means of the Kubelka-Munk mathematical transformation [27, 
28]: 
S
K
2R
R)(1
F(R)
2
    Eq. (2) 
where K is the absorption coefficient and S is the scattering coefficient. S depends on the 
number, size, shape, and refractivity of particles, while K depends on the absorbing species 
and the wavelength. It may be stated that R, the diffuse reflectance, is a function of the ratio 
K/S [29]. 
The relationship is a limitin
most important assumptions [30]: 
- the distribution of the scattered light is uniform and specular reflection is ignored, 
- the randomly distributed particles are smaller than the sample layer, 
- the particles are much larger than the wavelength of the illuminated light (to ensure the 
independence of S from wavelength) [30]. 
Thus, the diffuse reflectance of solid samples can be measured at several wavelengths to 
obtain spectra and both chemical and physical information can be gathered on various 
properties, including material identity, concentrations of chemical constituents, physical 
characteristics and complex evaluation criteria. The universal capabilities of this method are 
based on statistical algorithms, through which it is possible to establish a correlation between 
spectral information and the foregoing parameters 31, 32 . 
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3.4 Energy Dispersive X-ray Fluorescence Analyser (XRF) 
This proceeding examines the elemental range from sodium (Na) to Uranium (U), with a 
concentration range from ppm to 100%. 
An XRF instrument is typically comprised of an excitation source and a detection system. The 
principle is that an X-ray tube creates an incident X-ray, which excites the sample. Each 
element in the sample will fluoresce (or emit) a secondary X-ray at a characteristic energy. 
With its detection system, the amount and energy of fluoresced X-rays can be measured. In 
case the instrument is equipped by a software, it translates this information into the type and 
amount of each element present in the sample. A typical X-ray spectrum from an irradiated 
sample will display multiple peaks of different intensities. This proceeding is a fast and non-
destructive method to the sample, it can be used for analysis and in the industry for control of 
materials. Depending on the application, XRF can be produced by using not only X-rays but 
also other primary excitation sources like alpha particles, protons or high energy electron 
beams [33]. 
3.5 Mini-tablets  
Mini-tablets are considered to be a new innovative technological and therapeutical way within 
the solid dosage forms, with advantages. Their preparation is a new challenge in the 
technology of solid dosage forms, because of the small dimensions (suitable for 
multiparticulate dosage forms e.g. in chronotherapy, as they provide- right drugs, at right 
time; and effective healing; also in paediatrics).  
According to its definition, mini-tablets are compacts with diameters between 2 and 3mm 
[34]; they are a multiple unit dosage form with a low risk of dose dumping and a high degree 
of dispersion in the gastrointestinal tract (GI tract) and reproducible bioavailability. One of 
the most important issues in the global development of medicines for children is the 
suitability and acceptability of the dosage form in relation to age [35-37]. 
In my work, mini-tablets came to focus, as flowability could be studied from new aspects. As 
the diameter of the die cavity is very small, good flowability - a factor influenced by the 
particle size - is especially important. The questions may arise as to whether the particle size 
influences the compactibility of the tablets and, if so, what is the optimum particle size. Both 
the force of compression and the particle size are very important since the volume of the die 
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cavity and the diameter of the punches are very small, and the multiple-tip slim punches 
(resembling a number of needles side by side) can easily break under a higher force of 
compression [34].  
In the relevant literature [34-49], numerous advantages of mini-tablets can be found; among 
the advantages we can mention:  
 mini-tablets present many benefits over orally administered liquids,  
 delivery of accurate dose, 
 require fewer or less problematic excipients,  
 dry product formulation would improve drug stability,  
 maintaining steady plasma levels, 
 from the industrial point of view the product is cost-effective,  
 defined sizes and strengths can be easily produced , 
 convenience of administration and accurate dosing as compared to liquids, as they are 
easy to swallow (a positive aspect in paediatrics), 
 rapid dissolution of drug and absorption which may produce a rapid onset of action, 
 they tend to act as a good alternative to granules and pellets, 
 their direct compression is possible (this is important in the case of water-sensitive 
drugs), 
 their coating is possible (in a perforated coating pan or a fluid bed apparatus), 
 complex release profiles are possible (e.g. the. initial and maintenance doses in one 
capsule), 
 several chemically incompatible drugs can be compressed into mini-tablets, coated 
and combined in a single capsule, 
 they may offer a solution in paediatrics (the guidelines of the European Medicine 
Agency (EMA) suggest the improvement of the health of children in the European 
Union (EU Paediatric Regulation, Regulation (EC) No 1901/2006 of the European 
Parliament and of the Council on medicinal products for paediatric use, amended by 
Regulation (EC) No 1902/2006)). 
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As a disadvantage it should be borne in mind, that high dose drugs could not be transformed 
into mini-tablets, and due to their small size the powder of these tablets tends to stick to the 
die or punch to a greater extent or the powder flow may get affected [47, 49]. 
4. MATERIALS AND METHODS 
4.1 Materials 
Sorbitol was chosen as model material, which is used worldwide as a filling agent for direct 
compression in the pharmaceutical and food industries. It is named after the sorbus tree or 
rowan, in whose berries it was first discovered. It has been found in a number of other fruits, 
in all of which it acts as a natural anti-freeze and sweetener. First synthesized in 1925, it is 
today produced commercially in the form of D-sorbitol by the catalytic hydrogenation of D-
glucose 50 . 
Sorbitol is able to crystallise in different forms. This polymorphism is monotropic, i.e. some 
crystalline forms are unstable thermodynamically but stable in their molecular configuration. 
Among applications, we may use it as: 
 a humectant and a stabiliser, a cryoprotective agent, 
 a non-fermentable extract, 
 an aroma carrier, 
 for lowering the freezing point, 
 a non-cariogenic bulk sweetener suitable for diabetics, 
 a sweetener approved for food use in the majority of countries, 
 applications in animal-feed: feed for monogastrics, ruminants, 
 applications in pharmaceutical and cosmetic applications: in liquid forms, solid forms, 
injectable forms,cosmetics, toothpastes, 
 a humectant and a plasticiser for tobacco, papermaking, glues and adhesives, textile 
industry, leather industry, cream polishes, cellulose films, 
 a complexing agent, 
 miscellaneous properties: biological applications, casting, mortars and 
concrete,continuous liquid coolants, plastics industry, 
 chemical aspects: chemical intermediate for the synthesis of Vitamin C 50-54 . 
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Various sorbitol products are available commercially in the food and pharmaceutical 
industries: two crystalline forms (Samples 1 and 2 -
(Sample 3) (Merck, Darmstadt, Germany) were applied. 
Magnesium stearate (Ph. Eur.) was used as a lubricant in a quantity of 1 %. The specific 
surface area of magnesium stearate was 0,69 m2/g (BET, Brauner-Emett-Teller method). 
Arbocel A300 (JRS Pharma, Rosenberg, Germany) is a powdered, microcrystalline cellulose, 
and according to its function, it was used as a diluent and a binder.  
It is chemically inert excipient, is not metabolized by the human body; and can be used as an 
alternative to lactose, its natural fiber structure provides stable tablets with low friability 55, 
56 . 
4.2 Methods 
4.2.1 Material characterization/Particle Size Analysis 
A Laborlux S light microscope (Leitz, Wetzlar, Germany) combined with a colour image 
analysis system (Leica Quantimet 500MC/Q500 MC/, LEICA Cambridge Ltd., U.K.) proved 
valuable for particle size analysis.  
Altogether 24 feature parameters were measured: area, length, breadth, convex perimeter, 
equivalent diameter, Feret-diameters (0;112,5;135;157,5;22,5;45;67,5;90), orthoFeret (Feret 
diameters, sometimes known as calliper diameters, may be defined as the orthogonal distance 
between a pair of parallel tangents to the feature at the specified angle to the scan), perimeter, 
roundness, as well as X Max (F0), X Min (F0), Y Max (F90) and Y Min (F90). 
 
4.2.2 Morphological study 
The morphology of the particles was controlled by scanning electron microscopy (SEM) 
(Hitachi 2400 S, Hitachi Scientific Instruments Ltd., Tokyo, Japan).  
A Polaron sputter coating apparatus (Polaron Equipment, Greenhill, UK) was applied to 
induce electric conductivity on the surfaces of the samples. The air pressure was 1.3-13 mPa. 
The surfaces of the crystals were treated with gold for 60 s (coating thickness:  
18 nm).  
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4.2.3 Sieve analysis 
Analytic-sieve-machine (Retsch GmbH & Co., Haan, Deutschland) was used with sieve-
apertures of 125  
individual sieving-time was 5 minutes. 
4.2.4 Homogenization 
Powder mixing was performed with a Turbula mixer (Willy A., Bachofen Maschinenfabrik, 
Basel, Switzerland), 50 rpm for 10 min. 
4.2.5 Near Infrared Diffuse Reflectance Spectroscopy (NIR)
The diffuse reflectance (R%) of each fractionated sample was determined in the wavelength 
range 200-2500 nm by using a 5-mm thin-layered cell in the sample holder of a Hitachi 
(Japan) U-3501 UV/VIS/NIR spectrophotometer equipped with an integrating sphere (d=60 
mm) and a PbS detector. Measurements were made at the characteristic wavelengths of 1732 
nm, 1584 nm, 1208 nm, 1070.5 nm and 1034 nm. 
4.2.6 Flowability - Automated Powder Testing
The PTG powder testing system was used to measure the flow behaviour of granules and 
powders in compliance with the Ph. Eur. . This instrument is suitable for testing powder flow 
time, the measurement of the cone angle of the collected powder mound, measuring the 
weight, calculating the density and the volume of the powder cone as well as the Ph. Eur. 
"flowability" results, which measures the flow time of 100 g of sample through a specified 
pouring nozzle.  
Using the conical stainless steel funnel and the changeable nozzles of 10, 15 and 25 mm, the 
cone angle can also be tested. 
 
Fig. 2 Pharma Test PTG-1 powder testing equipment 
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The PTG analysis provides: 
 powder flow time of a pre-defined mass, 
 powder cone volume, 
 powder cone density, 
 cone angle (angle of repose), 
 flowability of 100 mg of product (Ph. Eur.), 
 amount of sample (mg in a preset time), 
 flow chart of sample (mg/time). 
 
4.2.7 Compression 
Compression was carried out with a Korsch EKO eccentric tablet machine  
(Korsch Maschinenfabrik, Berlin, Germany) mounted with strain gauges, and a displacement 
transducer  was also applied. The pressure force and displacement were calibrated. Slightly 
concave punches, 12 mm in diameter were used. 
The compression tools were single, flat-faced punches 10 mm in diameter (this was not 
possible with punches 3 mm in diameter, which easily break) furnished with strain gauges and 
a displacement transducer. The strain gauges allow the force of compressions on the upper 
and lower punches to be followed with equipment calibrated with a WAZAU HM-HN-30 kN-
D cell (Kaliber, Budapest, Hungary). The displacement transducer was fitted over the upper 
punch. The transducer distance accuracy was checked by using five measuring pieces of 
different thicknesses (2.0, 5.0, 7.5, 10.0 and 15.0 mm) under zero loads (Mitutoyo, Tokyo, 
Japan) 
Parameters: 
Pressure force (upper punch): 15  1 kN 
Relative air humidity: 48-50% 
 
Rate of pressing: 35 tabl./ min 
Extent of compression: 3x10 tablets 
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Compression procedure 
Samples, in a 1 L glass vessel were homogenized at 50rpm in a Turbula mixer (W.A. 
Bachofen, Basel, Switzerland). After mixing, the powders were compressed into tablets with 
an instrumented eccentric tablet machine (Korsch EK0, Berlin, Germany). The compression 
tools were single, flat-faced punches 10 mm in diameter (this was not possible with punches 3 
mm in diameter, which easily break) furnished with strain gauges and a displacement 
transducer. The strain gauges allow the force of compressions on the upper and lower punches 
to be followed with equipment calibrated with a WAZAU HM-HN-30 kN-D cell (Kaliber, 
Budapest, Hungary). The displacement transducer was fitted over the upper punch. The 
transducer distance accuracy was checked by using five measuring pieces of different 
thicknesses (2.0, 5.0, 7.5, 10.0 and 15.0 mm) under zero loads (Mitutoyo, Tokyo, Japan). The 
rate of compression was 36 tablets/min at 15 kN, an air temperature of 24 C and a relative 
humidity of 45%. The tablet mass was 400 mg. 
The relationship between the upper punch force and the upper punch displacement during 
compression is represented as a force-displacement profile (Fig. 3). 
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Fig. 3 Force-displacement diagram [57] 
Figure 3 (above) depicts three regions. E1 is the lost energy, corresponding to the 
rearrangement and packing in the die, E2 is the energy of compaction and E3 is the energy of 
elastic recovery [58]. 
The plastic behaviour of materials is very important in tablettability. Plasticity was described 
by the Stamm-Mathis relationship [58]: 
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The compressibility factor (Pr(mass)) (based on the compression data) was calculated via the 
following equation [57]: 
1
2
)( / Nmkg
Pa
mEW
Pr x
spec
x
mass   Eq. (4) 
where x is the tensile strength and Wspec is the specific work. Wspec expresses the effective 
work (E2) invested into the compression of unit mass (m) of the substance at a given 
compression. The tensile strength of the tablets was calculated according to Fell and Newton 
[59]:  
hD
F
x
2
          
Eq. (5)
 
 
where D is the diameter, F is the force and h is the thickness of the tablet. 
The crushing strength was investigated with a Heberlein apparatus (Flisa, Le Locle, 
Switzerland). The geometrical parameters were measured with a screw micrometer 
(Mitutoyo). The parameters of the tablets were determined 24 h after compression because of 
the texture change (elastic recovery). 
4.2.8 Energy Dispersive X-ray Fluorescence Analyser (XRF)
X-ray analysis was carried out with an energy dispersive X-ray fluorescence analyser 
(MiniPal, Philips Analytical, Almelo, The Netherlands). 
 
Fig. 4  Dispersive X-ray fluorescence analyser 
(MiniPal, Philips Analytical, Almelo, The Netherlands)  
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The advantage of this apparatus is that other equipment (e.g. TEM, SEM) is not necessary for 
determination of the elements. The preparation is very simple and the measurement is very 
rapid. 
The spectrum was evaluated by non-linear least squares fitting, based on the AXIL algorithm 
developed at the University of Antwerp. 
 
Characteristics of the measurements: 
 Sample handling: Types of samples: powder, pressed; sample size: solids, 
 12 mm in diameter and< 40 mm in height; sample changer: 12 positions with 
removable tray. 
 X-ray tube: Type: low-powered with side window  anode material: Rh; software 
controlled tube setting; voltage: 4-30 kV; current: 1- , max. tube power: 9 W; 
tube filters: 5 filters selected by software. 
 Detector: High-resolution Si-PIN diode (< 250eV at 5,9keV). 
 He purge: to improve identification of low atomic number elements such as Na, Mg 
and Al. 
 Inlet pressure: 1 bar 
 Gas purity: 99.996 % 
 Operating ambient temperature: 5-  
Measurement: 
 Channel code: Mg; compound name: Mg  
 Unit: ppm 
 Line name: KA 
 Measuring time: 600 s  
 Condition set: 4  
 Induced deep of Mg K  
The measurements were repeated 5 - 10 times. 
 
Some powder mixtures with different magnesium stearate contents were prepared for the 
calibration. The magnesium stearate contents were 2.1, 4.3, 8.5, 12.8 and 17.0 ppm. 
The calibration demonstrated a linear model (k = 0.000667; r = 0.9533). 
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5. RESULTS AND DISCUSSION 
Section I. 
5.1 Measurement of particle size and shape 
A light microscope combined with an image analysis system has proved valuable proceeding 
for particle size analysis.  
White light itself can resolve particles within the range of 0.2 to 100 m. This lower limit can 
be decreased to about 0.1 m by the use of ultraviolet light and to about 0.01 m by the use of 
the ultramicroscope 1 . 
 analysis involves several separate stages: the 
image is acquired by the hardware, and converted into electrical form which is stored in the 
computer memory, or on a mass storage system such as a hard disc. Most cameras provide an 
analogue signal, which must be converted to digital format before it can be processed by the 
computer. A frame grabber - a small piece of hardware which consists of an analogue to 
digital converter and some memory to store the picture, - can also be used; possibly with local 
processor for control purposes. The image can be stored in the computer memory as an array 
of numbers, each particular number representing a particular shade of grey 12 . 
500 particles (average) were measured separately from each unsieved sample, chosen 
randomly from the bulk of the materials. 
Among the possible 24 feature parameters, 4 most important ones (with mean, standard 
deviation, minimum and maximum) were measured; area, length (this is the length of the 
longest Feret measurements), breadth (the shortest of the Feret measurements), convex 
perimeter, as Table 1 shows. 
(These data refer  
Further feature parameters referring to shape  roundness and roughness - could be 
determined from the  
Roundness = (perimeter)2/(4  area 1.064)  Eq. (6)  
Roughness = perimeter/convex perimeter  Eq. (7) 
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Referring to Podczeck and co-authors 7, 8, 13 ; and followers, Rashid, Heinamaki et al. 60 , 
roundness as a shape factor gives a minimum value of unity for a circle in terms of the 
perimeter and area. (A perfectly round pellet gives a roundness factor of 1.0; the value 
increases as a function of the irregularity of the particle.) 
Roughness is the ratio of the total length of the boundary of the feature to the length of the 
polygon circumscribing the feature, formed by 64 tangents to its boundary, revealing the 
surface irregularities of the particle. 
A roughness value of 1.0 indicates that a particle (sphere) has a smooth surface; the value 
increases as a function of the irregularity of particle 7, 8, 12, 13, 60 . 
Table 1 Main characteristics of particles 
Sample  Length 
m 
Breadth 
m 
Perimeter 
m 
Convex 
perimeter 
m 
Roundness Roughness 
Sample 1 Mean 
S.D. 
286.41 
100.83 
207.2 
69.62 
889.68 
330.21 
793.4 
270.78 
1.47 
0.19 
1.12 
Sample 2 Mean 
S.D. 
344.1 
114.62 
245.17 
81.22 
1048.42 
373.01 
946.36 
306.17 
1.46 
0.25 
1.11 
Sample 3 Mean 
S.D. 
657.28 
205.95 
441.5 
134.54 
2101.07 
719.81 
1778.24 
542.43 
1.78 
0.34 
1.18 
 
The particle size range proved to be a more important characteristic of the size than a mean 
particle size value, associated with tablet formation 7 . 
The differences in particle size can be seen from the data. Sample 1 consists of the smallest 
crystals, and Sample 3 of somewhat larger particles. It can additionally be seen that the 
parameters display a rather high deviation. The roundness data reveal that all three samples 
consist of non-isometric particles; there is no difference in habit between Samples 1 and 2, but 
the degree of non-isometry of Sample 3 is clearly higher. It can be seen furthermore that the 
roughness values are higher than 1 in every case. This means that the surface of the particles 
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is uneven. There is a similarity in the cases of Samples 1 and 2, but the value for Sample 3 is 
a little higher, through the difference is not significant. 
From the histograms shown in Figures 5, 6, and 7 it can be stated, that the distribution of the 
various Sorbitol samples follows heterodisperse features. 
 
 
Fig. 5 Sample 1 - Histograms by Length and Breadth 
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Fig. 6  Sample 2 - Histograms by Length and Breadth 
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Fig. 7 Sample 3 - Histograms by Length and Breadth
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Regarding the histogramms (by length and breadth) of the commercially available sorbitol 
samples (unsieved, bulk), it can be seen that particles form a heterodisperse system. 
After the examinations 
with an analytical sieving machine for further tests; with vibration sieve-apertures of 250, 
 
The individual sieving time was 5 min. 
 
Table 2  Size ranges sieved from the samples 
Samples 
Fraction 
 
Sample 1* 
315-400 
400-630 
630-1000 
Sample 2** 
315-400 
400-630 
630-1000 
Sample 3** 
315-400 
400-630 
630-1000 
stirring rate: 10 rpm; ** without stirring
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5.2 Morphological study 
The application of the proceeding of scanning electron microscopy (SEM) was suitable for 
the detection of the shape and the surface of the individual particles. The habits of the 
particles are illustrated in Figures 8, 9, 10. It is clear that the shapes of the particles from the 
shown samples are irregular, and the surface is very uneven. These particles are agglomerates 
of smaller crystals. 
 
 
Fig. 10  Sample 3 
By comparing the SEM photos of the rather irregular particles with the calculated roughness 
data, a strong relationship can be seen: the smoother surface has resulted in the smaller 
roughness data (see in Table 1). 
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5.3. Test by NIR Spectroscopy [61] 
Fractions of the Samples were analysed with Near Infrared Spectroscopy.  
The spectra at certain, characteristic wavelengths tended to differ from each-other.  
 
Fig. 11 Near infrared spectra of the sieved sorbitol fractions 
Figure 11 above reveals that all the spectra of the fractions ran parallel to each other, which 
means that the chemical characteristics were constant during the industrial processing of the 
preparation. Since the sorbitol samples did not contain other excipients, the absorbance must 
be due to the analyte itself. The differences between the spectra lie in the physical 
characteristics of the sieved powder fractions, due to the different extents of light reflectance. 
Smaller particles have a smaller ratio K/S, a lower absorbance, and hence a higher R.  
 
Figure 12 displays the close relationship between the parameters for each fraction (mean 
particle size) and the F(R) values at 1584 nm. The increase in the baseline with decreasing 
sample powder particle size was neglected. 
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Fig 12 Relationship between particle size and NIR spectral data 
In the early days of NIR spectrophotometric analysis, the results were usually interpreted as a 
function of log 1/R rather than via the Kubelka-Munk relationship [30]; quantitative 
spectrometric analysis relies upon a linear relationship between the absorption or reflectance 
intensity and concentration [62].  
 
However, our results indicate that, in the evaluation of the physical characteristics of solid 
sorbitol samples, the transformation of the spectral data in accordance with the Kubelka-
Munk relationship can appropriately be used to find a good correlation between the particle 
characteristics and the diffuse reflectance data even at the single wavelength for the sorbitol 
samples tested. A linear relationship was also found between the mean particle size and the 
bulk density of the sieved fractions (Figure 13). 
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Fig. 13 Relationship between mean particle size and bulk density of sieved sorbitol fractions 
Summary 
According to the study, the commercially available sorbitol samples represent heterodisperse 
features. These bulks were unsieved; and due to their heterodispersity, particles were sieved 
into fractions with an analytical sieving machine in order to be suitable for further tests and 
analyses. Besides the exact size determination of the particles, the exact knowledge of their 
shape and surface was also in focus, as they have a strong effect on tabletting parameters. 
The application of the method of scanning electron microscopy (SEM) was a suitable tool for 
the detection of the shape and the surface of the individual particles. 
By comparing the SEM photos of the studied particles with the calculated roughness data, a 
strong relationship can be seen: the smoother surface has resulted in the smaller roughness 
data. 
The sieved fractions were also investigated by the analysis of Near Infrared Spectroscopy; 
and the findings gave good correlation regarding size determination. 
It can be concluded that NIR spectroscopy [4, 10, 11, 20-32, 62-64] has now entered a mature 
stage of development and is currently the most efficient method of performing both 
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qualitative and quantitative analysis; this method can also be used to characterize the particle 
characteristics, including the sizes of solid samples. 
 
Section II. 
5.4 The influence of the cohesion on the flowability characteristic [65] 
It is well known that the knowledge of the flow properties of powdered materials is very 
important in the pharmaceutical industry and the food industry. Good flowability is an 
essential characteristic of powdered materials during the filling of capsules and in tableting 
operations [66]. No simple definition of good flowability is to be found in the literature, but it 
is known that flowability is influenced by the particle size and shape, the particle size 
distribution and the bulk density [18, 67, 68]. 
On the basis of these new possibilties, the relationship between the particle parameters and 
the flowability well deserves consideration. 
5.4.1 Calculation of cohesional coefficient (C) 
It is well known that the flow of powder in a funnel is influenced by the cohesive forces 
between the particles, the frictional forces between the wall of the funnel and the particles, 
and the gravitational force. 
The cohesional coefficient is a function of the internal frictional coefficient, the friction 
between the particles and the wall of the funnel and the diameter of the particles. 
Small particles are very cohesive and do not flow well or free. If the particles are very small 
(<50 m), the cohesional forces are higher than the gravitational force and outflow is 
prevented. In the w is expected 69, 70 . Naturally, 
the diameter of the orifice also influences the flow. In this case, a larger diameter may 
improve the flow time. In the knowledge of the degree of cohesion, it is possible to choose a 
suitable orifice size, and punches and dies with suitable diameters during tableting. The 
degree of friction/cohesion can be expressed in terms of the cohesional coefficient, which can 
be calculated from the powder rheological parameters: 
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The mass of powder (m) which flows from the funnel is measured by a balance. It is 
determined by various parameters, as follows: 
h
D
m
4
2
 Eq. (8) 
where h is the height of the wall of orifice, D is the diameter of the orifice and is the density 
of the powder (bulk). 
The outflow of unit mass from the funnel can be described by the Second Law of Newton:  
i
iFam  Eq. (9) 
where m is unit mass of the powder, a  is an acceleration vector, and iF  describes the forces. 
The forces involve gravitational force and frictional forces. The gravitational force acts in a 
downward direction: 
hg
D
F nalgravitatio 4
2
                         Eq. (10) 
The forces of friction are caused by the interactions of the moving particles with the walls of 
the orifice and act in an upward direction: 
hDCFfrictional )(  Eq. (11) 
where C is the cohesional coefficient (including the friction coefficient between the particles 
and the wall of the orifice). The critical diameter D at which there is no flow can be calculated 
via the Newton equation of motion: 
DhChg
D
ha
D
44
22
 Eq. (12) 
In the event of no flow, the acceleration of unit mass is zero. 
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This gives  
gh
C
D
4
 Eq. (13) 
The cohesion force between the powder particles can be determined from the angle of repose 
( ) (Fig. 14.) 71  
 
Fig. 14 Schematic presentation of parameters influencingcohesion force.  
An individual particle at A on the surface of the cone is subjected to gravitational force (mg) 
in the downward direction and a cohesion force (Fc) in a direction perpendicular to the cone. 
When the particle is just about to move, the equation of motion can be expressed as follows: 
)cos(sin mgFCmg c  Eq. (14) 
where C is the cohesional coefficient between the particles,  is the angle of repose and m is 
the mass of the particle. Equation 14 shows that the more cohesive the powder, the larger the 
angle of repose. However, the cohesive stress, i.e. the cohesive force per surface area, is 
inversely proportional to d, the diameter of the particles. For the surface unit: 
mg
d
C
Fc  Eq. (15) 
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The solution of equation 14 for C gives: 
cos
d
4sin
cosd
2
1
C 2  Eq. (16) 
The main characteristics of particles are presented in Table 1 and the shape of the samples can 
be seen in Figs 8, 9 and 10. It was concluded that the shapes of the particles of all the samples 
are irregular and the surface is very uneven. 
The flowability of the unsieved samples was first tested (Table 3). 
The orifice of the equipment was 10 mm in all cases. The flow properties were tested without 
stirring. 
Table 3.  Flowability parameters of unsieved sorbitol 
Samples Flow 
time (s) 
Angle 
 
Volume 
(ml) 
Mass 
(g/100 ml) 
Bulk density 
(g/ml) 
Sample 1 8.2 33.6 87.2 39 0.447 
Sample 2 8 33.2 85.6 37.1 0.433 
Sample 3 7.8 33.6 87.1 44.8 0.515 
The data demonstrate that the differences in particle size and shape between the unsieved 
commercial products caused practically no appreciable difference in the flow parameters, the 
flow is mass flow.  
From the practical aspect of tableting, however, a homodisperse particle size distribution is 
very important because (together with the other components) it influences the rearrangement 
in the die cavity. A high deviation in particle size is unfavourable because it affects the 
flowability and the good filling in the die. If the deviation of the tablet mass is too high, there 
will be a high deviation in the active agent content in the tablets. In this case it is necessary to 
separate the materials into fractions. 
After the powder had been sieved, the rheological parameters of the various fractions were 
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(diameter 8 mm) in the flowability test accordingly to study the influence of particle size and 
orifice on the flowing time. A special problem arises during the tableting of small tablets, 
when the diameter of the punches and die is also smaller. The results are given in Table 4. 
Table 4 Flowability data on sample fractions 
Samples Fraction 
 
Flow 
time(s) 
Angle 
 
Volume 
(ml) 
Mass 
(g/100 ml) 
Density 
(g/ml) 
Sample 1* 315-400 
12.8 
SD 1.62 
32.6 
SD 0.86 
83.8 
SD 2.81 
41.8 
SD 0.74 
0.499 
SD 0.01
4 
400-630 14.4 
SD 0.82 
34.7 
SD 0.73 
90.7 
SD 2.43 
38.6 
SD 0.68 
0.425 
SD 0.01 
630-1000 
17.1 
SD 0.41 
36.1 
SD 0.2 
95.5 
SD 0.76 
32.3 
SD 0.74 
0.338 
SD 0.00
6 
Sample 2** 315-400 
12.4 
SD 0.07 
33.4 
SD 0.45 
86.5 
SD 1.39 
44.3 
SD 0.29 
0.512 
SD 0.00
5 
400-630 
13.5 
SD 0.23 
35.7 
SD 0.57 
94.3 
SD 1.87 
39.2 
SD 0.84 
0.416 
SD 0.01
2 
630-1000 
16.7 
SD 0.04 
35.8 
SD 0.55 
94.5 
SD 1.89 
35.7 
SD 0.2 
0.378 
SD 0.00
8 
Sample 3** 315-400 
11.6 
SD 0.13 
33.2 
SD 0.44 
85.8 
SD 1.53 
46.7 
SD 0.92 
0.545 
SD 0.00
8 
400-630 14.2 
SD 0.36 
35.3 
SD 0.66 
92.85 
SD 2.27 
43.5 
SD 0.43 
0.470 
SD 0.14 
630-1000 16.3 
SD 0.13 
34.9 
SD 0.86 
91.7 
SD 2.9 
38.4 
SD 2.76 
0.419 
SD 0.03 
stirring rate: 10 rpm; ** without stirring
For Sample 1, stirring (10 rpm) was necessary because of the shape of the particles. It is clear 
from the data in Table 4. that increasing particle size was accompanied by an increase in the 
flow time. The values of the angle of repose (except for Sample 1, where the angle increased 
somewhat) were practically the same.  
The volume steadily increased in the case of Sample 1. In the other two cases, the volume 
increased between the first two fractions (315-400 and 400-630 m), but on further increase 
in particle size, no increase in volume was apparent. 
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The data also demonstrate that the mass and bulk density of the heap generally correlate 
negatively with the particle size. This shows that the filling space depends on the particle size, 
which is very important in tablet making. 
The cohesional coefficient and the critical diameter were calculated from the data and are 
presented in Table 5. It is clear that the value of C increased with increasing angle of repose. 
Accordingly, we considered the possibility of a relationship between the cohesional 
coefficient and the angle of repose in this range of particle size. The angle of repose was 
found to vary linearly with the cohesional coefficient (y=ax+b, where x=cohesional 
coefficient, a=slope, y=angle of repose and b=intercept) with good correlation (R2>=0.972). 
It is also clear that the angle of repose depends on the particle size and shape, and that the 
cohesional coefficient therefore characterizes the flow properties of a powder. 
Table 5 Relationship between the cohesional coefficient and the angle of repose 
Samples Average 
diameter of 
particles in 
the fraction 
 
Angle of 
repose 
 
Cohesional 
coefficient 
(C) 
Minimum 
orifice 
diameter 
(D) (mm) 
S1 
358 32.6 0.01374 1.11 
515 34.7 0.01691 1.62 
815 36.1 0.02159 2.60 
S2 
358 32.8 0.01377 1.10 
515 33.4 0.01662 1.63 
815 35.7 0.02148 2.32 
S3 
358 32.4 0.01370 1.03 
515 33.2 0.01657 1.40 
815 34.3 0.02110 2.05 
The findings permit the prediction of the smallest orifice diameter (D) through which the 
particles can freely flow into the die cavity. This is very important, especially from the aspect 
of the preparation of minitablets, which are only 2-3 mm in diameter, and which can be filled 
in capsules used as multiparticulate dosage forms. Because of the small die diameter, its 
prediction in preformulation tests is an essential question.  
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Summary 
In order to characterize the most important particle parameters and flow properties, three 
commercial sorbitol samples were tested. A new coefficient (C = cohesional coefficient) was 
calculated and a relationship was found between this coefficient and the angle of repose as a 
function of the particle size (in this range), and the critical minimal orifice diameter could be 
calculated.  
As it was mentioned in the Introduction, the guidelines of the European Medicine Agency 
(EMA) suggest the application of a factorial design or an artificial neural network in the 
development of a dosage form and the new coefficient could be applied to decrease the 
number of necessary training factors as it combines some of the more important 
characteristics of the studied materials. 
The influence of cohesion on the flowability characteristic is especially important in the case 
of manufacture of minitablets measuring only 2-3 mm in diameter, which open up new 
possibilities in therapy, e.g. in the treatment of ocular disease 72  or in pediatrics  
36, 37, 73 . They can be filled into capsules or further compressed into larger tablets; and the 
latest developments are the multiparticulate modified release dosage forms 74,75 . 
 
Section III. 
5.5. Compactibility/compressibility study 
5.5.1. Study of the distribution of magnesium stearate [76]
According to the practice of tabletting and the relevant literature 77-81 , with the decrease in 
particle size, not only the parameters of flowability are deteriorating, but the friction between 
the die wall and the side of the tablet also tends to increase.  
One of the types of auxilliaries used to solve this problem are lubricants. They are commonly 
included in tablet formulations in order to reduce the die wall friction during both the 
compaction and the ejection of the tablet. Their presence, however, may cause undesirable 
changes in tablet properties. Lubrication itself, in pharmacy, consists in adding a small 
amount of  a lubricant to a powder or granule, this lubricant being a substance capable of 
eliminating the projections and thereby reducing friction when inserted between two rough 
surfaces 80-82 . 
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When a lubricant is added to a tabletting blend, it is distributed either as a free fraction or as a 
surface film on the carrier material. In tablet making, the most commonly used 
pharmaceutical lubricant is magnesium stearate. There are several direct and indirect methods 
by which the distribution of magnesium stearate on the surface of lubricated particles can be 
examined. Many researches, especially Rubinstein, have already dealt with the migration of 
magnesium stearate during tablet production 77-79; 83-86 . 
The aim of this experiment was to study the influence of particle size of sorbitol on the 
distribution of magnesium stearate in a tablet during compaction. A compact table-top energy 
dispersive X-ray fluorescence analyser was used to measure the elemental range from sodium 
(Na) to Uranium (U), with a concentration range from ppm to 100%. The magnesium content 
of magnesium stearate was measured. As mentioned above, the purpose of lubricants is to 
prevent two solids from making contact wich each other, or at least to limit such contact. 
Lubrication is also a surface phenomenon 83,84 . For this reason, the upper and lower 
surfaces of the tablets were analysed by energy dispersive X-ray fluorimeter.  
The spectrum can be seen in Figure 15, and the relevant data are displayed in Table 6. 
 
Fig. 15 X-ray energy dispersive spectrum of magnesium stearate 
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Table 6 Amount of magnesium on the surface of tablets. 
Tablet batch Particle size 
( m) 
Magnesium (ppm) 
Upper surface Lower surface 
1 250-315 23.06 
(SD=2.45) 
21.48 
(SD=1.28) 
2 316-400 24.58 
(SD=0.73) 
25.46 
(SD=4.36) 
3 401-630 25.28 
(SD=6.21) 
22.75 
(SD=2.01) 
4 631-1000 22.66 
(SD=1.48) 
22.59 
(SD=4.31) 
Practically no difference can be detected in the distribution of magnesium stearate on the 
upper and lower surfaces of the tablets. It can further be observed that the sorbitol particle size 
did not influence the distribution of magnesium stearate. It can be steated that magnesium 
stearate used with a low specific area exerts a lubricating effect on the surface of the tablets. 
It was also very interesting to study the distribution of magnesium stearate inside the tablets. 
Therefore microsections with different thicknesses were prepared from tablets of No. 2 and 4 
with the aid of abrasive paper. The thickness was determined with a screw-micrometer 
(Mitutoyo, Kawasaki, Japan) and the magnesium stearate concentration was measured on the 
surface of microsections. The results are displayed in Table 7. 
Table 7: Distribution of magnesium in the tablets 
 Tablet batch 2 Tablet batch 4 
 Origin Microsection Origin Microsection 
Thickness 
(mm) 
3.944 2.981 2.530 2.114 3.864 2.999 2.228 1.776 
Magnesium 
(ppm) 
24.58 
SD=0.73 
15.4 
SD=0.60 
13.2 
SD=0.90 
15.6 
SD=1.50 
22.66 
SD=1.48 
9.2 
SD=1.20 
4.6 
SD=2.20 
3.3 
SD=1.20 
It can be seen from the the data that the amount of magnesium stearate decreased 
progressively towards the middle of the tablets. It can additionally be established that it 
decreased to a higher degree in the case of tablets No. 4. This means that the particle size 
influences the distribution of magnesium stearate inside the tablets. Its distribution is better 
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inside tablets prepared from smaller particles. It can be stated that larger particles need more 
magnesium stearate with a low specific surface area, or another quality of magnesium stearate 
(e.g. a higher specific surface area). 
 
Summary 
It can be concluded, that the X-ray fluorescence analyser is a suitable means of measuring the 
amount of magnesium stearate on the surface of and inside tablets. The distribution of 
magnesium stearate with a low specific surface area is uniform on the surface, but it is 
disturbed by the higher particle size inside the tablets. Measurement with the energy 
dispersive X-ray spectrometer is very simple and the evalution of the results is very easy, 
other equipment (e.g. TEM, SEM) is not necessary for the determination of the elements. The 
preparation is very simple and the measurement is very rapid. 
5.5.2. Role and effect of the particle size (sorbitol) during the compression of common tablets 
and prediction of mini-tablet compression parameters 
The importance of particle size and shape has been shown previously; as they play important 
roles in particle formation and processing. They influence the intermediate and final products 
directly, and their effects are especially important in the manufacturing of mini tablets, 2-3 
mm in diameter. 
In this section of my Ph.D. Thesis, the role of particle size was studied during direct 
compression. Sorbitol was also chosen as model material and compression was achived with 
an instrumented tablet machine suitable for measurment of the force of compression, its 
software allowing calculation of the compression parameters.  
Through the extrapolation of the compression parameters, the force of compression required 
to produce mini-tablets 3 mm in diameter with a mass of 140 mg was predicted. 
Previously, the influence of the cohesion coefficient on the flowability of particles of sorbitol 
different sizes was presented (see in Chapter 5.4). This coefficient can be applied very well in 
the development of solid dosage forms, and especially in the case of mini-tablets 35-49, 87 .  
Later, the effects of particle size on the compactibility of normal sorbitol samples were 
investigated, and a mathematical model for mini-tablets through the extrapolation of the 
compression data was developed. 
37 
 
The compression of sorbitol alone was not possible as it sticks to the punches and the die 
wall. Powder mixtures were therefore prepared with microfine cellulose (Arbocel) as filler 
(Arbocel has no tendency to stick)  as shown by Table 8. 
Table 8. Compositions of samples 
Sample Components Proportions 
% 
1 Sorbitol 250-315 m 
Arbocel 
50 
50 
2 Sorbitol 315-400 m 
Arbocel 
50 
50 
3 Sorbitol 400-630 m 
Arbocel 
50 
50 
4 Sorbitol 630-1000 m 
Arbocel 
50 
50 
5 Sorbitol 250-315 m 
Arbocel 
70 
30 
6 Sorbitol 315-400 m 
Arbocel 
70 
30 
7 Sorbitol 400-630 m 
Arbocel 
70 
30 
8 Sorbitol 630-1000 m 
Arbocel 
Magnesium stearate 
70 
29 
1 
9 Sorbitol 250-315 m 
Arbocel 
Magnesium stearate 
70 
29 
1 
10 Sorbitol 315-400 m 
Arbocel 
Magnesium stearate 
70 
29 
1 
11 Sorbitol 400-630 m 
Arbocel 
Magnesium stearate 
70 
29 
1 
12 Sorbitol 630-1000 m 
Arbocel 
Magnesium stearate 
70 
29 
1 
 
Compression procedure 
The principles and details of the method of compression were presented in Chapter 4.2.7.  
The rate of compression was 35 tablets/min at 15 kN, an air temperature of 26 C and a 
relative humidity of 48%. The tablet mass was about 400 mg, and the diameter of punches 
was 10 mm. 
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The masses of the tablets were measured with an analytical balance with an accurancy of 1 
mg. The statistical analyses were carried out with Statistica for Windows (Statsoft Inc.). 
Compressibility and compactibility behaviour, which is essential during compression, 
depends on the rearrangement of the particles. If the rate at which a powder rearranges is too 
low, compression can give rise to brittle fracture and plastic flow in certain regions before a 
close arrangement has been achieved in other regions;hence, when compression is complete, 
the tablet formed will have a lower local density in that particular area 88 . 
 
Table 9 Important compression parameters of 10 mm tablets  
(50% Sorbitol, without lubricant) Force of compression: 15 1 kN 
Sample Fraction 
( m) 
E2 
(Nm) 
E3 
(Nm) 
Fw 
(Nm) 
PlS-M 
(%) 
Pr 
(Pa/Nmkg-1) 
Tensile 
strength 
(MPa) 
1 250-315 6.36 
SD:  0.12 
1.08 
SD:  0.34 
2.04 
SD:  0.12 
86.50 
SD:  2.37 
196.26 
SD:  3.71 
2.99 
SD:  0.01 
2 315-400 6.38 
SD:  0.18 
1.09 
SD:  0.12 
2.18 
SD:  0.25 
85.33 
SD:  1.56 
194.71 
SD:  4.06 
2.93 
SD:  0.01 
3 400-630 6.10 
SD:  0.11 
0.80 
SD:  0.13 
1.94 
SD:  0.08 
86.55 
SD:  0.36 
190.32 
SD:  10.11 
2.79 
SD:  0.09 
4 630-1000 6.32 
SD:  0.18 
1.05 
SD:  0.20 
2.00 
SD:  0.11 
85.76 
SD:  2.45 
174.93 
SD:  6.19 
2.65 
SD:  0.07 
 
Table 10 Important compression parameters of 10 mm tablets  
(70% Sorbitol, without lubricant) Force of compression: 15 1 kN 
Sample Fraction 
( m) 
E2 
(Nm) 
E3 
(Nm) 
Fw 
(Nm) 
PlS-M 
(%) 
Pr 
(Pa/Nmkg-1) 
Tensile 
strength 
(MPa) 
5 250-315 5.20 
SD: 0.09 
0.74 
SD: 0.06 
1.52 
SD: 0.05 
86.43 
SD: 0.46 
250.10 
SD: 3.31 
3.37 
SD: 0.01 
6 315-400 5.80 
SD: 0.12 
1.16 
SD: 0.15 
1.85 
SD: 0.14 
87.35 
SD: 0.85 
226.50 
SD: 4.88 
3.38 
SD: 0.01 
7 400-630 5.94 
SD: 0.31 
0.96 
SD: 0.17 
1.78 
SD: 0.11 
85.53 
SD: 1.35 
220.80 
SD: 9.98 
3.13 
SD: 0.32 
8 630-1000 5.54 
SD: 0.11 
0.97 
SD: 0.14 
1.49 
SD: 0.08 
85.57 
SD: 1.50 
234.70 
SD: 6.36 
3.47 
SD: 0.08 
 
It can be seen from the data (Tables 9 and 10) that, on increase of the sorbitol content in the 
powder mixture, the plasticity of the samples remained the same. This means that the smaller 
proportion of microfine cellulose (Arbocel) did not influence the deformability of the powder 
mixture. In spite of this, the deformation energy (E2) and the work of friction (FW) decreased 
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slightly. The compactibility/compressibility (Pr) and tensile strength of the powder mixture 
containing 70% sorbitol (Table 10) were higher than those of the mixture containing 50% 
sorbitol (Table 9) because of the formation of stronger solid bridges between the more 
numerous sorbitol crystals during the compression. This effect appeared in the mechanical 
(tensile) strength of the tablets. Bonferoni analysis revealed that the Sorbitol particle size 
influenced the compressibility behaviour and the mechanical strength of the tablets, but not 
significantly. Both parameters were lower in the case of 50% sorbitol. 
On increasing of the amount of sorbitol without magnesium stearate (Table 10), the work of 
friction was slightly, but not significantly higher for the 315-400 m and 400-630 m 
fractions. Pr decreased with the increase of the particle size. In spite of this, the tensile 
strength was almost the same.  
The influence of magnesium stearate can be seen in Table 11. 
Table 11 Important compression parameters of 10 mm tablets  
(70% Sorbitol, with lubricant) Force of compression: 15 1 kN 
Sample Fraction 
( m) 
E2 
(Nm) 
E3 
(Nm) 
Fw 
(Nm) 
PlS-M 
(%) 
Pr 
(Pa/Nmkg-1) 
Tensile 
strength 
(MPa) 
9 250-315 5.15 
SD: 0.08 
1.18 
SD: 0.11 
1.26 
SD: 0.12 
81.34 
SD: 1.55 
207.58 
SD: 8.04 
2.50 
SD: 0.08 
10 315-400 4.88 
SD: 0.07 
1.29 
SD: 0.13 
1.21 
SD: 0.08 
79.20 
SD: 1.66 
192.50 
SD: 7.90 
2.29 
SD: 0.09 
11 400-630 4.68 
SD: 0.24 
1.21 
SD: 0.09 
1.21 
SD: 0.12 
79.72 
SD: 1.20 
195.30 
SD: 9.94 
2.36 
SD: 0.13 
12 630-1000 4.78 
SD: 0.16 
1.33 
SD: 0.12 
1.22 
SD: 0.09 
78.12 
SD: 1.42 
158.50 
SD: 6.04 
1.95 
SD: 0.11 
 
Comparison with the data on the powder mixture without magnesium stearate clearly reveals 
that the plasticity (Pl2) was lower and the elastic recovery (E3) higher to small extents. The 
other parameters were generally lower. It is well known [89] that magnesium stearate can 
form a very thin hydrophobic layer on the surface of particles during mixing. This layer 
hinders the formation of strong solid bridges between the particles. This is the reason why 
magnesium stearate generally reduced the compression parameters, but this effect was not 
significant.  
The smallest particle size fraction produced the best compactibility in every case. Magnesium 
stearate decreased Pr, magnesium stearate being well known to be more extensively 
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distributed on the surface of the tablet. According to our findings, in the interior of the tablet, 
the degree of distribution of magnesium stearate depends on the particle size (see in Chapter 
5.5.1).  
The work of friction was uniform during the compression of sorbitol with 1% magnesium 
stearate, and this effect appeared in the other parameters as well. 
The data in Tables 9, 10, and 11 indicate that the 250-315 m fraction at higher sorbitol 
proportion is the most suitable for the formation of the most compact tablet. Therefore, the 
data on this fraction were chosen for the extrapolation to mini-tablets. 
5.5.3. Extrapolation to mini-tablets 
As mentioned above, the force of compression is a very important parameter in tablet 
compression. In the forthcoming part below, a simple method is given with which to 
determine a suitable force of compression for mini-tablet formation, and also formulas to 
determine the energy of making mini-tablets. The initial data are the mass (140 mg) and 
geometrical dimensions (height: 2 mm, diameter: 3 mm) of the desired mini-tablets. For a 
common normal tablet, the height should be a quarter of the diameter [90], but this is not 
valid in the case of mini-tablets [87]. They may also be isometric. In the calculation, we 
assume that the plasticity (PlS-M)), compressibility/compactibility factor (Pr(mass)) and the 
tensile strength ( ) are same for normal and mini tablets. We do this if the material 
parameters are identical in both cases. If these conditions are satisfied, we can write: 
   
                                  Eq.(17) 
    mm
m
xx
mEmE // 22
   Eq. (18) 
                       Eq. (19)
 
 
where m denotes the corresponding values for the mini-tablets. From equation 17, the size of 
the breaking force of the mini-tablet can be calculated as 
mm
m
EE
E
EE
E
32
2
32
2
mm
m
hD
F
hD
F 22
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              F
hD
hD
F
mm
m                   Eq. (20)  
where F  and 
m
F  are the forces of breaking of normal tablets and mini-tablets respectively. 
Then, the force of compression (pressure) for mini-tablets can be obtained from: 
pressure
m
m
pressure FF
F
F   Eq. (21) 
where Fpressure  and mpressureF  are the load forces in the cases of normal tablets and mini-tablets 
respectively. 
The calculations revealed that for the 250-315 m fraction the optimum force of compression 
was 2.5 kN (for Sample 5) and 2.3 kN (for Sample 9). 
The energy of plastic deformation (E2) and the energy of elastic deformation (E3) of mini-
tablets can be obtained from equations (18) and (19), respectively, via the forms 
22 Em
m
E
m
m    Eq. (22) 
mm E
E
EE
E 2
2
32
3 1   Eq. (23) 
The extrapolated values are listed in Tables 12, 13 and 14 which present the parameters 
predicted during the compression of mini-tablets. It is clear, that the tendencies are the same 
as for normal tablets. This justifies the suitability of the calculation specified aboved. 
Table 12  Important compression parameters extrapolated to mini-tablets 
 3 mm in diameter (Samples 1-4)
Sample Fraction 
( m) 
E2 
(Nm) 
E3 
(Nm) 
Fw 
(Nm) 
1 250-315 2.23 
SD:  0.04 
0.38 
SD:  0.12 
0.71 
SD:  0.04 
2 315-400 2.23 
SD:  0.06 
0.38 
SD:  0.04 
0.76 
SD:  0.09 
3 400-630 2.14 
SD:  0.04 
0.28 
SD:  0.05 
0.68 
SD:  0.03 
4 630-1000 2.21 
SD:  0.06 
0.37 
SD:  0.07 
0.70 
SD:  0.04 
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Table 13  Important compression parameters extrapolated to mini-tablets 
  3 mm in diameter (Samples 5-8)
Sample Fraction 
( m) 
E2 
(Nm) 
E3 
(Nm) 
Fw 
(Nm) 
5 250-315 1.82 
SD:  0.03 
0.26 
SD:  0.2 
0.53 
SD:  0.02 
6 315-400 2.03 
SD:  0.04 
0.41 
SD:  0.05 
0.65 
SD:  0.05 
7 400-630 2.08 
SD:  0.11 
0.33 
SD:  0.06 
0.62 
SD:  0.04 
8 630-1000 1.94 
SD:  0.04 
0.34 
SD:  0.05 
0.52 
SD:  0.03 
Table 14 Important compression parameters extrapolated to mini-tablets 
  3 mm in diameter (Samples 9-12)
Sample Fraction 
( m) 
E2 
(Nm) 
E3 
(Nm) 
Fw 
(Nm) 
9 250-315 1.80 
SD: 0.03 
0.41 
SD: 0.04 
0.44 
SD: 0.04 
10 315-400 1.71 
SD: 0.03 
0.45 
SD: 0.05 
0.42 
SD: 0.03 
11 400-630 1.82 
SD: 0.03 
0.47 
SD: 0.03 
0.43 
SD: 0.04 
12 630-1000 1.82 
SD: 0.03 
0.51 
SD: 0.04 
0.43 
SD: 0.03 
 
Summary 
The influence of various particle size fractions on the compressibility and compactibility of 
sorbitol revealed that the sorbitol 250-315 m fraction exhibited the greatest compactibility in 
the compression experiments when the mass of tablets was 400 mg, the diameter was 10 mm 
and the force of compression was 15 kN. The proportion of sorbitol increased, whereas the 
use of lubricant slightly decreased the compressibility factor (Pr(mass)) (based on the 
compression data), but the tendency was the same in each case. On increasing the particle 
size, the compactibility generally decreased, but not significantly. 
The extrapolation of the data on this basis indicated that 2.3-2.5 kN force of compression 
would be necessary to prepare mini-tablets 3 mm in diameter and 140 mg in mass. 
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6. FINAL CONCLUSIONS, NOVELTY, PRACTICAL USEFULNESS 
During my work, I have aimed to interpret the importance of particle size in tableting from a 
new point of view.  
Determination of particle size, as well as the importance of particle size and homodispersity 
are already well known; these factors bear special significance during direct compression. 
However, in practice, obtaining homodispersity by grinding is not always favourable. On the 
one hand, damages in the crystalline structure during grinding may lead to problems in 
stability, on the other hand they may induce undesirable interactions. What is more, 
manufacturers of auxilliaries tend to produce more and more, so- -
-
contain multicomponent, individual particles, the 
required effect.  
Besides these, mini-tablets  forming a special group of tablets, - are considered to be a new 
trend in modern therapy. During their preparation, the ensuring of appropriate particle size 
and favourable flowability is of special importance. 
 
Summarizing the final conclusions, novelty, and practical usfulness of my work, it can be 
stated: 
 I have found that the habit of the various, commercially available products is different; 
and in their heterodispersity diversity can be tracked. 
 I have found relationship between the sieved fractions of the samples and near infrared 
(NIR) spectra. 
 Based on the results of the flowability studies, I have determined the value of the 
cohesion coefficient by a mathematical-statistical method, which enables us to predict 
the size of the smallest punch diameter (die hole) suitable for particles to fill in via 
free-flow. 
 I have studied the effect of particle size on the distribution of magnesium stearate. 
Magnesium stearate, as lubricant is mainly responsible for reducing fricton arising 
between the die wall and the surface of the tablet. This effect could be detected in 
sorbitol with a smaller particle size, which was considered to be favourable. 
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 Based on the parameters of compressibility, I have determined the influence of 
particle size on the compressibilty/compactibilty of tablets. 
By extrapolating the results with mathematical-statistical calculations, the force of 
compression referring to preparing tablets with 3 mm in diameter, 2 mm in height, and 
140 mg in mass, has been determined. 
 
Finally, it can be stated: 
1., When receiving raw materials, the study of habit is essential. Furthermore, NIR analysis is 
suitable for not only the chemical identification of the material, but also for quick particle size 
determination. 
 
2., By the calculation of the cohesion coefficient (C), the time for development procedure of a 
dosage form can be shortened; as it can be used as a factor for a factorial design or an 
artificial neural network. 
 
3., Similarly, by extrapolating the results of the compressibilty parameters, the innovation of 
mini-tablets can be accelerated. 
 
4. Energy dispersive X-ray fluorescence analyser is a suitable method for carrying out 
pharmaceutical elemental impurity analysis. 
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